Streeting announced a collaboration with the world's largest pharmaceutical company, Lilly, which will include a five-year ...

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

Sir Keir Starmer and his health secretary have been lauding the potential of the new generation of weight-loss drugs. Given ...

Prime Minister Keir Starmer said weight-loss drugs like Novo Nordisk’s Ozempic and Eli Lilly and Co’s Mounjaro could help ...

Hims & Hers Health shares rose Monday after the Food and Drug Administration said compounding pharmacies could continue to ...

The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with ...

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

The future of the weight loss market might not revolve around GLP-1 drugs.

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...